| Aguiar, Sebastian (Samsara Therapeutics 201902 COO + Founder) |
Chief Operating Officer (COO) |
|
|
| Allen, Mark (Elevian 202209 CEO) |
Chief Executive Officer (CEO) |
Elevian |
|
| Ballal, Rahul (Mediar Therapeutics 202303 CEO before Imara) |
Chief Executive Officer (CEO) |
|
|
| Balthrop, Patrick J. (Apalachee Ventures 201602 Founding Prinicpal before Luminex 200405–2014 CEO) |
Principal (venture capital) |
Apalachee Ventures |
|
| Barookhian, Natanel (TechU Ventures 202403 Managing Partner) |
Managing Partner (investment firm) |
TechU Ventures |
|
| Barzi, Roberto (VitaTech SA 201902 Director) |
Investment Manager |
VitaTech S.A. (Zambon Family + other European high-net-worth private investors) |
|
| Benaich, Nathan (Air Street Capital 202103 General Partner) |
General Partner (venture partner) |
Air Street Capital (Nathan Benaich) |
|
| Bernardo, Joseph E. (Joe) (Linden Capital 201908 Operating Partner + BCG Senior Advisor before Thermo Fisher + Siemens) |
Partner (venture partner) |
Linden Capital Partners |
|
| Bissinger, Matthias (Business Angel 202203) |
n. a. |
|
|
| Bode, Tim (Business Angel) |
n. a. |
PERSON |
|
| Boël, Harold (Sofina 202109 CEO) |
Chief Executive Officer (CEO) |
|
|
| Borges, Peter (Business Angel 202302) |
n. a. |
|
|
| Boury, Guillaume (Telos Impact 202309 Investment Manager) |
Investment Manager |
Telos Impact |
|
| Brandenburg, Mario (Member of German Parliament + Technology Policy Spokesman of FDP) |
n. a. |
|
|
| Bremus, Christoph (Phenospex 201909– Chief Commercial Officer before Eppendorf + DASGIP) |
n. a. |
OTHER |
|
| Brennecke, Marcus (EQT Partners 201706 Partner + Investment Advisor to EQT VII fund) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
|
| Breugelmans, Matthias (Elastrin 202209 CEO) |
Chief Executive Officer (CEO) |
Elastrin Therapeutics |
|
| Brüggen, Jochen |
n. a. |
PERSON |
|
| Calikowski, Tomasz (EU 201403 Scientific Officer of European Commission) |
Administrative Officer (personnel) |
|
|
| Choveaux, David (Sparta Biodiscovery 202309 Business Development + Operations) |
Business Development Manager / Strategy Manager |
Sparta Biodiscovery Ltd. |
|
| Clemens, Ralf (CureVac 201603 SAB + Supervisory Board Member before GSK Biologicals + Novartis) |
scientific advisory board (SAB) |
|
|
| Coleman, Michael (InGeneron 201005 Managing Director) |
n. a. |
|
|
| Collan, Robert (FRIBA Investment 202106 Managing Director) |
Managing Director |
FRIBA Investment |
|
| Colsman, Wolfgang (Zontal 202305 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
|
| Connelly, Robert T. (Elicio Therapeutics 201903– CEO before Pronutria + Pulmatrix + Diversys/Domantis + IGEN Intl) |
Chief Executive Officer (CEO) |
|
|
| Cook, Kathryn (NuCicer 202211 CEO + Co-Founder) |
n. a. |
|
|
| Coucke, Marc (Alychlo before Omega Pharma 1987– CEO + Founder) |
Chief Executive Officer (CEO) |
Alychlo (family office of Marc Coucke) |
|
| Dawkins, Keith D. (Shockwave 2019– CMO before Boston Scientific) |
Board member, non-executive |
|
|
| de Wilde, Henk (LiveVentures 202012 CEO) |
Chief Executive Officer (CEO) |
LiveVentures |
|
| Deigin, Yuri (Youth Bio 202209 CEO) |
Chief Executive Officer (CEO) |
Youth Bio |
|
| Dhar, Rakhshita (Bayer 202206 Senior Director of Venture Investments Health at Leaps by Bayer) |
Investment Manager |
Bayer (Group) |
|
| Dombrosky, John (Bayer 201910– CEO of Oerth Bio) |
Chief Executive Officer (CEO) |
Bayer (Group) |
|
| Ebert, Eric (Wando Founder) |
n. a. |
|
|
| Ebitsch, Susanne (Univ Leipzig 202210 CEO of b-ACT matter) |
Chief Executive Officer (CEO) |
University of Leipzig |
|
| Eckhardt, Jürgen (Bayer 201904 Head of Leaps by Bayer) |
Investment Manager |
Bayer (Group) |
|
| Ehle, Dirk (Bayer 201308 Global Head of Bayer HealthCare Animal Health Division) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
|
| Elff, Manfred (Niedersächsisches Zentrum für Biomedizintechnik und Implantatforschung 201009 Managing Director) |
Managing Director |
Niedersächsisches Zentrum für Biomedizintechnik und Implantatforschung (NZ-BMT) |
|
| Ellenbogen, Henry (Durable Capital 202106 Managing Partner + Chief Investment Officer) |
Managing Partner (investment firm) |
Durable Capital Partners LP |
|
| Faeh, Urban (Bruker 201001– President Bruker Optics division joined Bruker 1998 as sales manager) |
President/Director/Head Business Group/Unit/Division |
Bruker BioSciences (Group) |
|
| Fatscher, Hans Peter (Qiagen 201710– VP + Head of Qiagen Custom Solutions business) |
President/Director/Head Business Group/Unit/Division |
Qiagen Custom Solutions (business unit) |
|
| Feller, Christine |
n. a. |
Baden-Württembergische Bank AG |
|
| Fischer, Hartmut (A&M Labor 201201 Managing Director) |
Managing Director |
A&M Labor für Analytik und Metabolismusforschung Service Gmb |
|
| Forster, Ken (Momenta 202406 Executive Director) |
Board member, executive |
Momenta (VC) |
|
| Fratacci, Thomas (SPRIM Global Investments 202302 CFO) |
n. a. |
|
|
| Fritz, Jutta (NanoSphere Biotechnologies 202207 CBO before Blackfield + Kinaxo+ Max Planck Innovation) |
Business Development Manager / Strategy Manager |
|
|
| Fry, Nigel (Schauenburg 202309– CEO of Schauenburg Analytics Group before Antylia Scientific + GE Healthcare) |
Chief Executive Officer (CEO) |
Schauenburg (Group) |
|
| Fürstner, Alois (Max Planck 1993– MPI for Coal Research Mühlheim) |
Professor |
Max Planck Society for the Advancement of Science |
|
| Fäh, Urban (Bruker Corp 201802 President of Bruker Optics) |
President/Director/Head Business Group/Unit/Division |
Bruker BioSciences (Group) |
|
| Germa, Caroline (Transcenta 202311 CMO + Board Member at Ymmunobio before AstraZeneca) |
Chief Medical Officer (CMO) |
Transcenta |
|
| Ghobarah, Adam (Top Harvest Capital 202209 Founder before Google + Google Ventures) |
Company Founder |
Top Harvest Capital (Adam Ghobarah) |
|
| Ghosh, Kunal (Inscopix 202211 CEO + Founder) |
Chief Executive Officer (CEO) |
Bruker (Group) |
|
| Gies, Otto H. (3B Scientifc) |
n. a. |
|
|
| Girod, Patrick (Herculis Partners 201702 Managing Partner) |
Managing Partner (investment firm) |
Herculis Partners S.A. |
|
| Giuliani, Giammaria (Gisev Family Office 202006 Co-Founder + Board Director at Cutiss AG) |
Company Founder |
Gisev (Family Office of Giammaria Giuliani) |
|
| Griesinger, Christian (Max Planck 1999– Director + Scientific Member MPIBPC Göttingen before Univ Frankfurt Professor) |
Professor |
University of Frankfurt (Goethe-Universität) |
|
| Gräf, Isabella (Eidos Therapeutics Co-Founder) |
Company Founder |
Eidos Therapeutics Inc. |
|
| Haass, Christian (Professor) |
Professor |
|
|
| Hamester, Meike (Bruker 201302 Director ICP-MS Global Market Development + Product Management) |
Product Manager (personnel) |
Bruker (Group) |
|
| Hamilton, Amanda (ADC Therapeutics 201911 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
|
|
| Hardwick, Andy (Schauenburg 201912 Commercial Director at Schauenburg Analytics Ltd) |
Chief Commercial Officer (CCO) |
Schauenburg (Group) |
|
| Heidecker, Martin (AMR Action Fund 202301 Chief Investment Officer before Boehringer Ingelheim Venture Fund) |
Investment Manager |
AMR Action Fund |
|
| Heumann, Hermann (Silantes GmbH 201902 Managing Director) |
Managing Director |
Silantes GmbH |
|
| Hofmann, Siegfried |
n. a. |
Holtzbrinck (Group) |
|
| Hohmann, Hans-Guenter |
n. a. |
|
|
| Hombach, Michael (Univ Zürich 201106 Institute of Medical Microbiology) |
n. a. |
|
|
| Horland, Reyk (TissUse GmbH 202010– CEO before VP Business Development since founding in 2010) |
Chief Executive Officer (CEO) |
TissUse GmbH |
|
| Horn, Friedemann (Univ Leipzig 201602 Professor at Faculty of Medicine + Co-Founder Ribolution Health GmbH) |
n. a. |
|
|
| Iannone, Lucio (Bayer 201904 at Leaps by Bayer) |
Investment Manager |
Bayer (Group) |
|
| Jacobi, Philipp (Quadriga Capital 201811 Managing Partner) |
Managing Partner (investment firm) |
Quadriga Capital Eigenkapitalberatung GmbH |
|
| Jagiella, Manfred (Endress+Hauser 201711 Group Board Member responsible for analytical business) |
Board member, executive |
Endress+Hauser (Group) |
|
| Jain, Kewal |
n. a. |
Jain PharmaBiotech |
|
| Janositz, Paul |
journalism |
|
|
| Johnson, Wendy (Gemini Advisors 201503 Managing Director before ProQuest Investments + Aires Pharmaceuticals) |
Managing Director |
|
|
| Jones, David T. W. (Heidelberg Epignostix 202407 General Manager + Co-Founder) |
Managing Director |
|
|
| Karg, Elisabeth (Blue Ribbon Partners 202011 Project Manager) |
n. a. |
Blue Ribbon Partners GmbH |
|
| Kaufmann, David R. (Gates Foundation 201904 CMO of Gates Medical Research Institute before Merck Research Laboratories |
Chief Medical Officer (CMO) |
GATES Group (family of Bill Gates) |
|
| Khalil, Iya (Novartis 202005– Global Head of AI Innovation Center before Co-Founder of GNS Healthcare) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
|
| Khaljani, Ehsan |
n. a. |
|
|
| Kiprov, Dobri (Lyfspn 202209 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Lyfspn |
|
| Klingan, Franz-Robert (Bain & Co 201610 Partner) |
Consultant (economic/technology) |
Bain & Company |
|
| Klöckner, Ingo (Bayer 202210 Portfolio Strategy + Reporting at Leaps by Bayer) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
|
| Knorr, Till (Business Angel) |
n. a. |
|
|
| Koncar, Michael (KonValue 201810 Founder + CEO of KonValue Group + Validogen (former VTU Technology)) |
Chief Executive Officer (CEO) |
KonValue (Group) |
|
| Kreibohm, Philipp (Home24 Founder) |
n. a. |
|
|
| Kumar, Aman (Oaktree 202208 Co-Portolio Manager of Life Sciences Lending at Oaktree Capital Management) |
n. a. |
Oaktree Capital Management L.P. |
|
| Kurian, Thomas (Alphabet 201906 CEO of Google Cloud) |
n. a. |
|
|
| Kölpin, Alexander (WestTech Ventures 201602 COO + Partner) |
Chief Operating Officer (COO) |
WestTech Ventures |
|
| Langner, Stefan (Bruker 201308 Marketing Communications Manager at Bruker Nano Analytics division) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
|
| Lautner, Christian (Heal Capital 202306 Founding Managing Partner + Eternity.Health 202107 MD + Co-Founder) |
Managing Director |
Heal Capital (Heal.Capital) (Group) |
|
| Lee, Michael (Syngenta 201809 Director at Syngenta Ventures) |
Investment Manager |
Syngenta (Group) |
|
| Lee-Chin, Michael (Portland Holdings 202106 Chairman + Founder) |
Board member, executive |
Portland Holdings |
|
| Lehmann, Holger (Merck (US) 201502 Head Drug Discovery at MSD Animal Health) |
Research & Development Manager |
Merck (US) (MSD) (Group) |
|
| Leo, Giovanni (EFI Lake Geneva Ventures I 202306 Partner + EBAMed 202306 Co-Founder + Chair) |
Partner (venture partner) |
|
|
| Leoni, Lorenzo (TiVenture Fund 201802 Managing Director + Gain Therapeutics 201802– interim CEO before Telormedix) |
Managing Director |
Fondazione Centenario BancaStato |
|
| Levine, Carly (AMR Action Fund 202301) |
Investment Manager |
AMR Action Fund |
|
| Lillig, John (IRORI Technologies 201311– CEO before Brooks Life Science Systems + Nexus Biosystems) |
Chief Executive Officer (CEO) |
Drug Discovery Partners International |
|
| Lokey, Houlihan |
consulting (economic) |
|
|
| Lucas, Svetlana (Tizona Therapeutics 201510 VP Business Development) |
Business Development Manager / Strategy Manager |
Tizona Therapeutics Inc. |
|
| Lukesch, Michael (Valanx Biotech 202311 CEO + Founder) |
n. a. |
|
|
| Maier, Robert (ladenzeile.de Founder) |
n. a. |
|
|
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
